A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation.
Saved in:
| Title: | A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation. |
|---|---|
| Authors: | Ge AY; School of Medicine, University of California, San Francisco, San Francisco, CA, 94158, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA., Arab A; Arc Institute, Palo Alto, CA, 94304, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA., Dai R; Arc Institute, Palo Alto, CA, 94304, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA., Navickas A; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, 94158, USA., Fish L; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, 94158, USA., Garcia K; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, 94158, USA., Asgharian H; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, 94158, USA., Goudreau J; Arc Institute, Palo Alto, CA, 94304, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, 94158, USA., Lee S; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, 94158, USA., Keenan K; Tumor Cell Targeting Research Unit, Research, GSK, Collegeville, PA, 19426, USA., Pappalardi MB; Tumor Cell Targeting Research Unit, Research, GSK, Collegeville, PA, 19426, USA., McCabe MT; Tumor Cell Targeting Research Unit, Research, GSK, Collegeville, PA, 19426, USA., Przybyla L; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA.; Laboratory for Genomics Research, San Francisco, CA, 94158, USA., Goodarzi H; Arc Institute, Palo Alto, CA, 94304, USA. Hani@arcinstitute.org.; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA. Hani@arcinstitute.org.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA. Hani@arcinstitute.org.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA. Hani@arcinstitute.org.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, 94158, USA. Hani@arcinstitute.org., Gilbert LA; Arc Institute, Palo Alto, CA, 94304, USA. Luke@arcinstitute.org.; Department of Urology, University of California, San Francisco, San Francisco, CA, 94158, USA. Luke@arcinstitute.org.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA. Luke@arcinstitute.org. |
| Source: | Scientific reports [Sci Rep] 2024 Oct 29; Vol. 14 (1), pp. 25940. Date of Electronic Publication: 2024 Oct 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
